Publications
- Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study2020 | First Faculty of Medicine
- Single-agent ibrutinib in RESONATE-2TM and RESONATETM versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia2019 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment of relapsed chronic lymphocytic leukemia2019 | First Faculty of Medicine
- Interlaboratory variability of CD34+stem cell enumeration: A pilot study to national external quality assessment within the Czech Republic2010 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Other malignancies in the history of CLL: an international multicenter study coducted by ERIC, the European Research Initiative on CLL, in HARMONY2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...